Taragenyx Successfully Close Funding Round

Taragenyx have just complete a new round of funding worth over £600,000 from Kelvin Capital, Lancaster Capital and the Scottish Investment Bank.

The investment will be used by the company to fund continued global customer expansion and for further work into their proprietary self-healing implant technologies.

Iain McDougall, CEO of Taragenyx said
“It’s been an incredible journey for us so far. After two years of hard work and prudent risk taking we’ve achieved so many things and made great progress.”

The full article can be read on Business Quarter here